UPDATE 1-Mallinckrodt buys immunotherapy maker Therakos for $1.33 bln
August 10, 2015 at 07:13 AM EDT
Aug 10 (Reuters) - Dublin-based drugmaker Mallinckrodt Plc said it would buy immunotherapy company Therakos Inc in a deal valued at about $1.33 billion, its second major acquisition this year to strengthen its hospital offerings.
